ClinicalTrials.gg
RecruitingNCT07789314REACTUpdated Oct 21, 2026

Just-in-Time Coping Prompts for Reactive Digital Behavior in College Students

An interventional study of Momentary coping prompt and Active control message in Emotional Regulation, Alcohol Drinking in College and Emotional Eating, sponsored by University of Florida. Recruiting at 1 site in United States. Open to participants aged 18 Years to 22 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by University of Florida · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 21, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 22 Years
Sex
All
01

Study summary

This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcohol, and eating in response to emotions. Participants wear a wrist device and answer brief check-ins on their phone several times a day for five weeks in total, starting with a 1-week run-in. During the following 4 weeks, a study app sometimes sends a short coping message at moments when the wrist device and check-ins suggest emotions are shifting quickly. Whether a message is sent at any given moment is decided at random, and the study compares what participants do in the short window afterward. The study is a pilot designed to test whether the approach is feasible and to estimate how large its effects are.

Read the detailed description

REACT is a five-week micro-randomized trial in University of Florida students age 18 and older. Participants complete a baseline battery, wear a Garmin Venu 3, and respond to five to six smartphone check-ins per day. Week one is a no-prompt run-in that establishes each participant's own baseline distribution of momentary affective variability, indexed by the mean square of successive differences on consecutive affect ratings. From week two through week five, the app evaluates up to six decision points per day. A decision point is flagged when the participant's current variability exceeds their own 80th percentile threshold, computed within person rather than against a group average. At each available decision point the app randomizes with probability 0.5 whether to deliver a brief coping message, and if so selects a message type from those eligible in that context. Availability rules exclude sleep, stale device data, a 60-minute cooldown, a daily cap, and any safety override. Proximal outcomes are drawn from the first check-in within two hours after the decision point. Analysis uses weighted and centered least squares to estimate causal excursion effects, with pre-specified moderators.

02

Conditions studied

  • Emotional Regulation
  • Alcohol Drinking in College
  • Emotional Eating
  • Aggression

Keywords

  • just-in-time adaptive intervention
  • micro-randomized trial
  • ecological momentary assessment
  • wearable sensor
  • emotional volatility
  • college students
03

In context

Emotional Regulation

545 studies on the registry are indexed under Emotional Regulation; 188 are open to participants now.

This study's planned enrollment of 80 is close to the median of 79 across 498 interventional studies indexed under Emotional Regulation.

Browse Emotional Regulation studies →

Lead sponsor

University of Florida is the lead sponsor of 1,287 studies on the registry; 199 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently enrolled University of Florida student
  • Age 18 years or older
  • Owns a smartphone used daily
  • Willing to wear a wrist-worn device and complete brief check-ins several times daily for approximately five weeks

Exclusion criteria

Exclusion Criteria:

  • Varsity student-athlete governed by the university athletic association
  • Unable to complete study procedures in English
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Coping prompt delivered

    Decision points at which the randomization outcome is to deliver a brief cognitive-behavioral or acceptance-based coping message. Message type is selected at random from those eligible in the participant's current context. Every participant contributes decision points to this condition.

    Behavioral: Momentary coping prompt

  • Active comparator
    No coping prompt or active control message

    Decision points at which the randomization outcome is not to deliver a coping message. A brief neutral, non-directive acknowledgment message may be delivered as an active control so that receiving any message can be separated from receiving a coping message. Every participant contributes decision points to this condition.

    Behavioral: Active control message

Interventions

  • BehavioralMomentary coping prompt

    A single short message of one to three sentences delivered to the participant's smartphone at a randomized decision point, taking roughly fifteen to thirty seconds to read. Messages apply cognitive-behavioral techniques including thought records, perspective-taking, decatastrophizing, cost-benefit checks, implementation intentions, and behavioral redirection, or acceptance-based techniques including cognitive defusion, acceptance, values anchoring, urge surfing, and present-moment grounding. Delivery is capped at four messages per day with a minimum sixty-minute interval and is confined to participant-set waking hours. Messages may be dismissed without responding.

  • BehavioralActive control message

    A brief neutral acknowledgment message matched to the coping messages on delivery mechanism and approximate length, containing no coping technique or behavioral suggestion.

06

What researchers measure

Primary outcomes

  1. Momentary urge to post or reply reactively, score on a 7-point scale.

    Self-reported urge to post or reply about something upsetting, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Higher scores indicate greater urge. Analyzed as a causal excursion effect comparing decision points at which a coping message was delivered with those at which it was not.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5.

  2. Momentary urge to drink alcohol, score on a 7-point scale.

    Self-reported current urge to drink alcohol, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Higher scores indicate greater urge. Analyzed as a causal excursion effect.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5.

  3. Momentary emotional influence on eating, score on a 7-point scale.

    Self-reported rating of how much emotions influenced eating since the previous check-in, rated 1 to 7 at the first check-in within two hours after a randomized decision point. Analyzed as a causal excursion effect.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5.

Secondary outcomes

  1. Momentary reactive online behavior since the previous check-in, self-reported occurrence

    Self-reported occurrence of posting or replying while upset since the previous check-in, reported yes or no at the first check-in within two hours after a randomized decision point.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5.

  2. Number of standard drinks consumed since the previous check-in, self-reported count

    Self-reported number of standard drinks consumed since the previous check-in.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5.

  3. Loss-of-control eating rating, score on a 7-point scale

    Self-reported sense of losing control while eating since the previous check-in, rated 1 to 7.

    Time frame: Within 2 hours after each randomized decision point, across weeks 2 to 5

  4. Proportion of scheduled check-ins completed

    Number of completed check-ins divided by number of scheduled check-ins. Pre-registered feasibility benchmark is 75 percent.

    Time frame: Through study completion, approximately 5 weeks per participant.

  5. Proportion of delivered prompts receiving a response

    Number of prompts receiving a rating response divided by number of prompts delivered. Pre-registered benchmark is 60 percent.

    Time frame: Through study completion, approximately 5 weeks per participant.

  6. Proportion of waking hours with valid wearable data

    Hours of valid physiological data divided by estimated waking hours. Pre-registered benchmark is 80 percent.

    Time frame: Through study completion, approximately 5 weeks per participant.

  7. Proportion of enrolled participants retained to study end.

    Number of participants completing the study divided by number enrolled. Pre-registered benchmark is 85 percent.

    Time frame: Through study completion, approximately 5 weeks per participant.

  8. Prompt helpfulness rating, score on a 7-point scale

    Participant rating of how helpful the coping prompts were, rated 1 to 7.

    Time frame: Week 3 and end of study, approximately week 5.

  9. System Usability Scale total score.

    System Usability Scale (Brooke, 1996) total score, range 0 to 100, higher scores indicating better usability.

    Time frame: End of study, approximately week 5.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared outside the research team. This is a pilot study collecting sensitive behavioral and biological data from a small identifiable campus population, and the informed consent does not provide for external sharing of individual-level data. Aggregate results will be published.

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Oct 21, 2026
Sites
University of Florida is now Recruiting
Oct 21, 2026
Eligibility
Maximum age 89 Years→22 Years
Oct 21, 2026
Contact
Study contact's phone or email changed: y•••@ufl.edu→s•••@hhp.ufl.edu. See the current contact
Oct 13, 2026
Show all 2 updates
  1. Oct 21, 2026
    Not yet recruiting→Recruiting
    University of Florida is now Recruiting
    Eligibility Maximum age 89 Years→22 Years
    + 4 other changes: verification date, date precision, description and design details
  2. Oct 13, 2026
    Contact Study contact's phone or email changed: y•••@ufl.edu→s•••@hhp.ufl.edu. See the current contact

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07789314
Responsible party
Sponsor
First posted
Aug 27, 2026
Start date
Sep 21, 2026
Primary completion
May 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Yonghwan Chang, PhD
Contact
smashresearchlabs@hhp.ufl.edu
352-294-1664
Yonghwan Chang, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion